A constitutively activating mutation of the luteinizing hormone receptor in familial male precocious puberty.

Article Details

Citation

Shenker A, Laue L, Kosugi S, Merendino JJ Jr, Minegishi T, Cutler GB Jr

A constitutively activating mutation of the luteinizing hormone receptor in familial male precocious puberty.

Nature. 1993 Oct 14;365(6447):652-4.

PubMed ID
7692306 [ View in PubMed
]
Abstract

Familial male precocious puberty (FMPP) is a gonadotropin-independent disorder that is inherited in an autosomal dominant, male-limited pattern. Affected males generally exhibit signs of puberty by age 4. Testosterone production and Leydig cell hyperplasia occur in the context of prepubertal levels of luteinizing hormone (LH). The LH receptor is a member of the family of G-protein-coupled receptors, and we hypothesized that FMPP might be due to a mutant receptor that is activated in the presence of little or no agonist. A single A-->G base change that results in substitution of glycine for aspartate at position 578 in the sixth transmembrane helix of the LH receptor was found in affected individuals from eight different families. Linkage of the mutation to FMPP was supported by restriction-digest analysis. COS-7 cells expressing the mutant LH receptor exhibited markedly increased cyclic AMP production in the absence of agonist, suggesting that autonomous Leydig cell activity in FMPP is caused by a constitutively activated LH receptor.

DrugBank Data that Cites this Article

Polypeptides
NameUniProt ID
Lutropin-choriogonadotropic hormone receptorP22888Details